Ms. Nicole Lemerond - 05 Jun 2025 Form 4 Insider Report for GeoVax Labs, Inc. (GOVX)

Role: Director
Signature: /s/ Nicole Lemerond
Issuer symbol: GOVX
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2025, 09:51:40 UTC
Previous filing: 14 Feb 2025
Next filing: 20 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lemerond Nicole	Director	C/O GEOVAX LABS, INC., 1900 LAKE PARK DR, SUITE 380, SMYRNA	/s/ Nicole Lemerond	06 Jun 2025	0001941712

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GOVX	Stock Option	Award	$0	+10,000		$0.000000	10,000	05 Jun 2025	Common Stock	10,000	$2.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

Content

This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.